BORR Borr Drilling

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
124
BORR

Borr Drilling Limited

https://borrdrilling.com/

The pps is at .669 as of this post.


BORR DRILLING LIMITED – CONTEMPLATED EQUITY OFFERING OF USD 40-50 MILLION
Hamilton, Bermuda, 22 September 2020

Borr Drilling Limited (“Borr” or the “Company”) (NYSE: “BORR”, OSE: “BDRILL”) is contemplating offering USD 40-50 million in new depository receipts (the “Offer Shares”), representing the beneficial interests in the same number of the Company’s underlying common shares, each with a par value of USD 0.05, and each at a subscription price of USD 0.70 (the “Subscription Price”) (the “Equity Offering”).

Certain investors have pre-committed to subscribe for Offer Shares in the Equity Offering in the amount of approximately USD 30 million, of which individual members of the Company’s Board of Directors (the “Board”) and the Company’s executive management have pre-committed for a total of USD 3 million.

The net proceeds from the Equity Offering will be used to strengthen the Company’s working capital and for general corporate purposes. The Company may also use part of the proceeds to repurchase bonds under the Company’s USD 350 million convertible bond loan on term acceptable to the Board.

The application period opens today, on 22 September 2020, at 22:00 CET/4:00pm EST and ends at 08:00 CET/2.00am EST on 25 September 2020. The Company may, in its own discretion, extend or shorten the application period at any time and for any reason.

Completion of the Equity Offering is subject to (i) the Board resolving to consummate the Equity Offering and allocate the Offer Shares; (ii) publication of a prospectus approved by the Financial Supervisory Authority of Norway, relating to the listing of the Offer Shares and certain of the offer shares in the May private placement (hereinafter the “Listing Prospectus”); (iii) with respect to Tranche 2, the approval by the SGM of the increase of the Company’s authorized share capital; and (iv) the Offer Shares, including the underlying new common shares, having been fully paid and legally issued. Each applicant acknowledges that the Equity Offering may be cancelled if the conditions are not fulfilled. Tranche 1 may, in the Company’s discretion, be completed without Tranche 2.

Settlement of Tranche 1 of the Equity Offering is expected on or about 29 September 2020. Settlement of Tranche 2 of the Equity Offering is expected on or about 13 October 2020.

The Offer Shares, representing the beneficial interests in the same number of common shares in the Company, will only be listed on the Oslo Stock Exchange upon issuance. No Offer Shares will be offered or sold to the public in the United States or in transactions on the NYSE.

Subject to completion of the Equity Offering, Board approval, and the prevailing market price of the Company’s depository receipts, the Company intends to carry out a subsequent offering of new depository receipts in the Company (the “Subsequent Offering”). The Subsequent Offering will, on the basis of an offering- and listing prospectus (the “Offering Prospectus”) to be approved by the Norwegian Financial Supervisory Authority, and subject to shareholder approval at the SGM, be directed towards holders of OSE depository receipts who: (i) hold OSE depository receipts as per the end of trading on 22 September 2020, as registered in VPS as of 24 September 2020, (ii) are not allocated Offer Shares in the Equity Offering, and (iii) are not resident in a jurisdiction where such offering would be unlawful or, for jurisdictions other than Norway, would require any prospectus, filing, registration or similar action (the “Eligible Shareholders”). The Eligible Shareholders will be granted non-transferable subscription rights. The subscription period in the Subsequent Offering is expected to commence following publication of the Offering Prospectus, estimated in end October 2020. The subscription price in the Subsequent Offering will correspond with the Subscription Price in the Private Placement. Investors allocated Offer Shares in the Equity Offering will not be given the right to participate in a Subsequent Offering.

The securities offered in the Equity Offering and any Subsequent Offering have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Forward looking statements

This press release includes forward looking statements, which do not reflect historical facts and may be identified by words such as “may”, “expect”, “may”, “will” and similar expressions and include statements relating to the contemplated Equity Offering including the conditions to the offering, pre-commitments to subscribe for Offer Shares and the intended use of the net proceeds of the Equity Offering and the Subsequent Offering. Such forward-looking statements are subject to risks, uncertainties, contingencies and other factors could cause actual events to differ materially from the expectations expressed or implied by the forward-looking statements included herein, including risks related to the Company’s ability to complete the contemplated Equity Offering on contemplated terms or at all including whether the conditions to the offering will be satisfied and the use of the proceeds and other factors described in the section entitled “Risk Factors” in our filings with the Securities and Exchange Commission. Such risks, uncertainties, contingencies and other factors could cause actual events to differ materially from the expectations expressed or implied by the forward-looking statements included herein. These forward-looking statements are made only as of the date of this release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

https://borrdrilling.com/news/borr-drilling-l...0-million/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Orbis Celebrates 20 Years of Eye Care in Macau

Updated Category News Views 2

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Continue Reading
Ramaco Resources Faces Stock Shake-Up Amid Distribution

Updated Category News Views 0

Stock Shake-Up In The Coal Industry Something's brewing in the coal mines of West Virginia, and it isn't just the usual dust settling. Ramaco Resources, Inc. (NASDAQ: METC), the metallurgical coal titan, is feeling the heat from some unexpected stock market turbulence, and it's got everyone in the investment trenches scratching their heads. The Yorktown Energy Partners'...

Continue Reading
What to Expect from KeyCorp at Barclays Event

Updated Category News Views 4

KeyCorp's Next Move: An Insider's View Yep, circle that calendar, folks. Looks like KeyCorp's gonna be laying it all out there for the financial world to see. Clark Khayat, their numero uno money guy, is hitting the stage at the Barclays Global Financial Services Conference on Sept. 14. So grab the popcorn—or, more like, your portfolio tracker—because this could get...

Continue Reading
Charity's Bold Move: Acquiring Wayfinder for K-12 Impact

Updated Category News Views 1

Public Charity Expands Into Education Well, here's something that's bound to turn a few heads: a fast-growing public charity has just made its first acquisition in the K-12 sphere by snapping up Wayfinder. The stakes are getting interesting. When a charity starts playing in the acquisition space, you're looking at a change in strategy that deserves close attention. Why...

Continue Reading
YSL Beauty’s Block Party Series Rocks London's Scene

Updated Category News Views 3

YSL Beauty: More Than a Brand, a Cultural Movement London felt a distinct pulse this past weekend as YSL Beauty kicked off another sizzling event in its Block Party series. This one wasn't just another Instagrammable gathering; it was the kind of scene that shifted the cultural needle. What started in Madrid has now become a roving spectacle that sweeps across cities,...

Continue Reading
XTEND Launches on NYSE Amid Market Milestones

Updated Category News Views 2

XTEND Steps Into the NYSE Spotlight Out of the gate, let's talk about XTEND—a name that's about to make waves on the New York Stock Exchange. With their debut under the ticker XTND, these folks are slamming their flag into the financial terrain like a knight ready for battle. XTEND, an AI-powered defense robotics and software outfit, isn't just joining the party—it's...

Continue Reading
Argo Biopharma's BW-20805 Shows Promise in HAE Phase II Trial

Updated Category News Views 1

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...

Continue Reading
Ed Markey's Political Future on Shaky Ground in MA

Updated Category News Views 2

Massachusetts Voters Voice Desire for Change Ever seen an old engine stutter and cough before finally quitting? That's what Ed Markey's political career is starting to feel like. A fresh poll has surfaced, casting doubt over his steady grip on his longstanding Senate seat in Massachusetts. People are yearning for fresh faces and new ideas like never before. It's as if the...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 4

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
Parents Champion Meta's Online Safety Agreement

Updated Category News Views 3

Any old-timer in the market game will tell you this: safeguarding the next generation runs deeper than just chasing profits. A recent poll by the Coalition to Empower our Future reveals something that ain’t too surprising if you’ve been paying attention. Parents all over the nation are nodding along to Meta’s new move to bolster online protections for younger folks....

Continue Reading

Top 5 Most Recently Viewed Articles

Hedge Fund Strategies: Insights for 2025 Market Dynamics

Updated Category News Views 2154

The Shifting Landscape of Hedge Fund Investments for 2025 As we navigate toward 2025, hedge fund investors are increasingly drawn to macro strategies, reflecting a transformative phase in the financial markets. This trend is largely driven by the evolving political landscapes and their potential impacts on economic conditions globally. Investors are strategically...

Continue Reading
EHang Secures Over $22 Million Investment from Enpower and Others

Updated Category News Views 128

EHang's Strategic Investment Boosts Urban Air Mobility Growth GUANGZHOU, China - EHang Holdings Limited (Nasdaq: EH), renowned for its leadership in Urban Air Mobility (UAM), has recently announced a significant strategic investment exceeding US$22 million. This investment is spearheaded by Zhuhai Enpower Electric Co., Ltd., a leading provider of power systems for new...

Continue Reading
e.l.f. Beauty, Inc. Class Action: Understand Your Rights

Updated Category News Views 123

e.l.f. Beauty, Inc. Class Action Overview Attention investors! A class action lawsuit has been filed against e.l.f. Beauty, Inc. This important case involves investors who purchased shares of this makeup brand during a specific time frame and may have experienced financial losses due to misleading information. Details of the Class Action Case e.l.f. Beauty, known for its...

Continue Reading
CareCloud Set to Lead AI Healthcare Discussion at Tech Event

Updated Category News Views 109

CareCloud to Showcase AI Innovations at Upcoming Tech Conference CareCloud, Inc. (Nasdaq: CCLD, CCLDO), known for its pioneering role in AI-driven healthcare technology solutions, is gearing up to take center stage at the upcoming virtual tech conference presented by Maxim Group LLC. This exciting event will feature an enlightening Healthcare IT Panel on June 3, where...

Continue Reading
Understanding Accenture's Short Interest Trends and Impacts

Updated Category News Views 216

Understanding Accenture's Short Interest Trends Accenture's short percent of float has notably dropped by 4.0% since its previous report. Currently, the company has approximately 6.03 million shares sold short, representing about 0.96% of all available regular shares for trading. This figure indicates that, with current trading volume, traders would require an estimated...

Continue Reading